The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Behçet's disease – a contemporary review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Criteria for diagnosis of Behçet's disease
Weichsler, B., Davatchi, F., Lehner, T., O’Duffy, J. D., Rigby, A. S., & Gregory, J. K. (1990) · The Lancet · Cited by 3,082
Sakane, T., Takeno, M., Suzuki, N., & Inaba, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411707 · Cited by 1,594
[Criteria of diagnosis of Behcet's disease].
Hamza, M., Zribi, A., & Ben Ayed, H. (1976) · PubMed · Cited by 1,148
Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients
Akman-Demir, G., Serdaroglu, P., & Tasçi, B. (1999) · Brain · doi:10.1093/brain/122.11.2171 · Cited by 793
Kural-Seyahi, E., Fresko, I., Seyahi, N., Ozyazgan, Y., Mat, C., Hamuryudan, V., Yurdakul, S., & Yazici, H. (2003) · Medicine · doi:10.1097/00005792-200301000-00006 · Cited by 768
EULAR recommendations for the management of Behçet disease
Hatemi, G., Silman, A., Bang, D., Bodaghi, B., Chamberlain, A. M., Gul, A., Houman, M. H., Kötter, I., Olivieri, I., Salvarani, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080432 · Cited by 718
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
A Controlled Trial of Azathioprine in Behçet's Syndrome
Yazici, H., Pazarli, H., Barnes, C. G., Tüzün, Y., Özyazgan, Y., Silman, A., Serdaroğlu, S., Oğuz, V., Yurdakul, S., Lovatt, G. E., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002013220501 · Cited by 647
Behcet, H. (1937) · Medical Entomology and Zoology · Cited by 645
Uveitis in Behçet disease: An analysis of 880 patients
Tugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., Huseyin Altunbas, H., & Urgancioglu, M. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.03.022 · Cited by 631
DESCRIPTION OF BEHCET'S SYNDROME IN THE HIPPOCRATIC THIRD BOOK OF ENDEMIC DISEASES
Feigenbaum, A. (1956) · British Journal of Ophthalmology · doi:10.1136/bjo.40.6.355 · Cited by 554
Hamuryudan, V., Mat, C., Saip, S., Ozyazgan, Y., Siva, A., Yurdakul, S., Zwingenberger, K., & Yazici, H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00004 · Cited by 456
Behçet’s disease, the Silk Road and HLA‐B51: historical and geographical perspectives
Verity, D. H., Marr, J. E., Ohno, S., Wallace, G. R., & Stanford, M. R. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540301.x · Cited by 438
Yazici, H., Tüzün, Y., Pazarli, H., Yurdakul, S., Ozyazgan, Y., Ozdoğan, H., Serdaroğlu, S., Ersanli, M., Ulkü, B. Y., & Müftüoğlu, A. U. (1984) · Annals of the Rheumatic Diseases · doi:10.1136/ard.43.6.783 · Cited by 411
Current Concepts in the Etiology and Treatment of Behçet Disease
Evereklioglu, C. (2005) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.04.009 · Cited by 393
A double-blind trial of colchicine in Beh�et's syndrome
Yurdakul, S., Mat, C., T�z�n, Y., �zyazgan, Y., Hamuryudan, V., Uysal, �., ?enocak, M., & Yazici, H. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h · Cited by 383
Ohno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Sugita, S., Ueno, S., Yoshizaki, K., & 稲葉, 午. (2004) · PubMed · Cited by 343
Current Concepts in the Etiology and Treatment of Behçet Disease
Androudi, S. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2005.12.006 · Cited by 333
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51
Direskeneli, H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.11.996 · Cited by 317
Clinical manifestations of BehÇet's disease: an analysis of 2147 patients
Gurler, A., Boyvat, A., & Tursen, U. (1997) · Yonsei Medical Journal · doi:10.3349/ymj.1997.38.6.423 · Cited by 312
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease
Tursen, U., Gurler, A., & Boyvat, A. (2003) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2003.01741.x · Cited by 305
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Sfikakis, P. P., Markomichelakis, N., Alpsoy, E., Assaad-Khalil, S., Bodaghi, B., Gul, A., Ohno, S., Pipitone, N., Schirmer, M., Stanford, M., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem034 · Cited by 301
Azathioprine in Behçet's syndrome. Effects on long‐term prognosis
Hamuryudan, V., Özyazgan, Y., Hizli, N., Mat, C., Yurdakul, S., Tüzün, Y., Şlenocak, M., & Yazici, H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400425 · Cited by 280
Epidemiology of Adamantiades-Behçet's disease.
Zouboulis, C. C. (1999) · PubMed · Cited by 276
Kotter, I. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.423 · Cited by 274
Alpsoy, E., Durusoy, C., Yilmaz, E., Ozgurel, Y., Ermis, O., Yazar, S., & Basaran, E. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.4.467 · Cited by 273
Clinical features of Behçet's disease in children: An international collaborative study of 86 cases
Koné-Paut, I., Yurdakul, S., Bahabri, S. A., Shafae, N., Ozen, S., Özdogan, H., & Bernard, J. L. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70368-3 · Cited by 250
Infliximab for Recurrent, Sight-Threatening Ocular Inflammation in Adamantiades–Behçet Disease
Sfikakis, P. P., Kaklamanis, P. H., Elezoglou, A., Katsilambros, N., Theodossiadis, P. G., Papaefthimiou, S., & Markomichelakis, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00025 · Cited by 229
The use of interferon α in behçet disease: review of the literature
Kötter, I., Günaydin, I., Zierhut, M., & Stübiger, N. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.09.010 · Cited by 226
The Role of Heat Shock Protein, Microbial and Autoimmune Agents in the Aetiology of Behget's Disease
Lehner, T. (1997) · International Reviews of Immunology · doi:10.3109/08830189709116842 · Cited by 214
Mucocutaneous Lesions of Behçet's Disease
Alpsoy, E., Zouboulis, C. C., & Ehrlich, G. E. (2007) · Yonsei Medical Journal · doi:10.3349/ymj.2007.48.4.573 · Cited by 209
Bodaghi, B., Gendron, G., Wechsler, B., Terrada, C., Cassoux, N., Thi Huong, D. L., Lemaitre, C., Fradeau, C., LeHoang, P., & Piette, J.-C. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.101550 · Cited by 198
Hassard, P. V., Binder, S. W., Nelson, V., & Vasiliauskas, E. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.22556 · Cited by 176
Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease
Hasan, A., Fortune, F., Wilson, A., Warr, K., Lehner, T., Sanderson, J., Shinnick, T., Mizushima, Y., van der Zee, R., & Stanford, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90868-5 · Cited by 175
Gastrointestinal involvement in Behçet's syndrome: a controlled study.
Yurdakul, S., Tüzüner, N., Yurdakul, I., Hamuryudan, V, & Yazici, H. (1996) · Annals of the Rheumatic Diseases · doi:10.1136/ard.55.3.208 · Cited by 175
Immunology and functional genomics of Beh�et's disease
Zierhut, M., Mizuki, N., Ohno, S., Inoko, H., G�l, A., Ono�, K., & Isogai, E. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-2333-3 · Cited by 140
Mapping the HLA association in Behçet's disease: A role for tumor necrosis factor polymorphisms?
Ahmad, T., Wallace, G. R., James, T., Neville, M. J., Bunce, M., Mulcahy‐Hawes, K., Armuzzi, A., Crawshaw, J., Fortune, F., Walton, R. T., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10815 · Cited by 140
Resistant Behçet Disease Responsive to Anakinra
Botsios, C., Sfriso, P., Furlan, A., Punzi, L., & Dinarello, C. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00018 · Cited by 131
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008
Fürst, D. E., Keystone, E. C., Kirkham, B., Fleischmann, R., Mease, P. J., Fc, B., Smolen, J. S., Kalden, J. R., Burmester, G. R., Braun, J., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.100834 · Cited by 129
Stanford, M. R., Whittall, T., Bergmeier, L. A., Lindblad, M., LUNDIN, S., Shinnick, T. M., Mizushima, Y., Holmgren, J. R., & Lehner, T. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02520.x · Cited by 121
Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximab
Robertson, L. P. (2001) · British journal of rheumatology · doi:10.1093/rheumatology/40.4.473 · Cited by 108
A double-blind trial of depot corticosteroids in Behçet's syndrome
Mat, C., Yurdakul, S., Uysal, S., Gogus, F., Özyazgan, Y., Uysal, Ö., Fresko, İ., & Yazici, H. (2005) · Rheumatology · doi:10.1093/rheumatology/kei165 · Cited by 105
Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome
Hamuryudan, V., Mat, C., Saip, S., et al. (1998) · Annals of Internal Medicine · Cited by 91
Bank, I., Duvdevani, M., & Livneh, A. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2003.1 · Cited by 87
Phipps, P. A., Stanford, M. R., Sun, J., Xiao, B., Holmgren, J. R., Shinnick, T. M., Hasan, A., Mizushima, Y., & Lehner, T. (2003) · European Journal of Immunology · doi:10.1002/immu.200390025 · Cited by 84
MEFVgene is a probable susceptibility gene for Behçet's disease
İmirzalıoğlu, N., Dursun, A., Tastan, B., Soysal, Y. D., & Yakicier, M. C. (2005) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740510017931 · Cited by 83
The influence of pregnancy on BehÇet's disease
Bang, D., Chun, Y. S., Haam, I. B., Lee, E., & Lee, S. (1997) · Yonsei Medical Journal · doi:10.3349/ymj.1997.38.6.437 · Cited by 80
Çalgünerı, M., Öztürk, M. A., Ertenli, İ., Kiraz, S., Apraş, Ş., & Özbalkan, Z. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.5.492 · Cited by 74
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease
Triolo, G., Vadalà, M., Accardo-Palumbo, A., Ferrante, A., Ciccia, F., Giardina, E., Citarrella, P., Lodato, G., & Licata, G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.560 · Cited by 72
Efficacy of TNF blockade in cyclophosphamide resistant neuro-Behcet disease
Ribi, C., Sztajzel, R., Delavelle, J., & Chizzolini, C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055434 · Cited by 69
Efficacy and safety of systemic recombinant interferon‐alpha in Behcet's disease
Georgiou, Monastirli, Pasmatzi, Gartaganis, Goerz, & Tsambaos (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00159.x · Cited by 63
Specific interleukin‐1 gene polymorphisms in Turkish patients with Behçet's disease
Coskun, M., Bacanlı, A., Sallakçı, N., Alpsoy, E., Yavuzer, U., & Yeğin, O. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00253.x · Cited by 63
Remission of Behçet's syndrome with TNFα blocking treatment
Rozenbaum, M., Rosner, I., & Portnoy, E. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.3.283-a · Cited by 59
Verjans, G. M. G. M., van Hagen, P. M., van der Kooi, A., Osterhaus, A. D. M. E., & Baarsma, G. S. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00208-4 · Cited by 55
Houman, H., Hamzaoui, A., Ghorbal, I. B., Khanfir, M. S., Feki, M., & Hamzaoui, K. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.07.005 · Cited by 47
The Monitoring of Immunosuppressive Drugs: A Pharmacodynamic Approach
Yatscoff, R. W., & Aspeslet, L. J. (1998) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199810000-00002 · Cited by 44
Drug Insight: anti-tumor necrosis factor therapies for the vasculitic diseases
Langford, C. A. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0825 · Cited by 21
Evereklioğlu, C. (2007) · European Journal of Echocardiography · doi:10.1016/j.euje.2006.12.007 · Cited by 10
Stanford, M. R. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.381 · Cited by 2
Cited by
Choi, J., Ho, J. H., Pasoto, S. G., Bunin, V., Kim, S. T., Carrasco, S., Borba, E. F., Gonçalves, C. R., Costa, P. R., Kallas, E. G., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39020 · Cited by 326
Immunopathogenesis of Behcet's Disease
Tong, B., Liu, X., Xiao, J., & Su, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00665 · Cited by 282
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Interleukin-1, inflammasomes, autoinflammation and the skin
Contassot, E., Beer, H.-D., & French, L. E. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13590 · Cited by 130
Metadata
- Authors
- Mendes, D., Correia, M., Barbedo, M., Vaio, T., Mota, M., Gonçalves, O., & Valente, J.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 32
- Issue
- 3-4
- Pages
- 178-188
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W2127082380
- Cited by
- 320
- References
- 59
- FWCI
- 23.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.